Hyderabad-based Divi’s Laboratories Limited on Wednesday said the US Food and Drug Administration (USFDA) inspected its Unit-1 at Lingojigudem village in Choutuppal mandal, near here in July. The inspection was for the pre-approval of product and general current good manufacturing practices. The audit concluded with minor observations, primarily about the additional records for further improvement of existing records, a company release said.
Top Section
Explore Business Standard